Evidence map›Paper›PMID 40166522›Full record

ArticleCureus2025

Novel Repair Technique for Iatrogenic Femoral Artery Pseudoaneurysms Using a Suture-Mediated Closure Device Combined With Bidirectional Guidewire Crossing: A Case Report.

Eiji Miyauchi, Syousei Osako, Ryo Arikawa, Naoya Oketani, Mitsuru Ohishi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eiji MiyauchiDepartment of Cardiology, Kagoshima City Hospital, Kagoshima, JPN.
Syousei OsakoDepartment of Cardiology, Kagoshima City Hospital, Kagoshima, JPN.
Ryo ArikawaDepartment of Cardiology, Kagoshima City Hospital, Kagoshima, JPN.
Naoya OketaniDepartment of Cardiology, Kagoshima City Hospital, Kagoshima, JPN.
Mitsuru OhishiDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel approach for iatrogenic femoral artery pseudoaneurysm (IFAP) using a suture-mediated closure device and bidirectional guidewire percutaneously and intravascularly will be presented in this case report. We report a case of a 73-year-old male patient who faced a complication due to an IFAP following a percutaneous coronary intervention. Manual compression and thrombin injection combined with intravascular balloon inflation were not effective. We then inserted a guidewire percutaneously to use a suture-mediated closure device, but it could not pass through the pseudoaneurysm neck into the common femoral artery. We then attempted a novel technique involving bidirectional guidewire crossing to use the suture-mediated closure device. First, two guidewires were inserted into the pseudoaneurysm cavity percutaneously and intravascularly. Second, the intravascular guidewire was replaced with a snare using a microcatheter to catch the percutaneous guidewire and pull it through the pseudoaneurysm neck into the femoral artery. Third, the percutaneous guidewire was replaced with a 0.035 guidewire to use the suture-mediated closure device. Finally, we confirmed that the IFAP disappeared angiographically. Our new approach could be an alternative method for treating difficult cases. Additional studies may be required to evaluate the long-term safety and efficacy of this approach.

Indexed as

bidirectional approachendovascular treatment (evt)iatrogenic complicationiatrogenic pseudoaneurysmvascular closure device efficacy

Identifiers

PMID40166522
PMCPMC11955786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.